VeinTech
PrivateLast Round
VC Round
Jun 9, 2025
Total Funding Raised
$4.07M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VeinTech operates in Healthcare & Life Sciences and is based in Perth. Its latest recorded funding round was a Grant round in June 2025.
VeinTech is a medical technology company that develops ultrasound-based imaging devices to assist clinicians in performing intravenous cannulation procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VeinTech Comparables
Compare VeinTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NextVein LLC | 86% | |
| AccuVein | 86% | |
| CAREstream America | 81% |
For institutional investors. Book with your work email.
VeinTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 9, 2025 | ||||
| Grant | Jun 9, 2025 | ||||
| Grant | Feb 13, 2024 | ||||
| Grant | Apr 6, 2023 | ||||
| Seed | Aug 1, 2022 | ||||
Grant | Jul 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VeinTech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scale Investors | Seed |
| Perth Angels | Seed |
| Future Health Research and Innovation Fund | Grant |
| Rhode Island Life Science Hub | Grant |
| Australian Government Department of Industry, Science and Resources | Grant |
| Brisbane Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 407% MoM.
- Jun 9, 2025
$750K grant from Rhode Island Life Science Hub.
For institutional investors. Book with your work email.
VeinTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VeinTech's valuation, stock price, and market status.
Is VeinTech a public or private company?
VeinTech is a private company.
What is the current stock price of VeinTech?
VeinTech is a private company, so its shares have no public market price. Caplight tracks VeinTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VeinTech worth (valuation)?
Valuation information for VeinTech is not publicly available.
Can I buy VeinTech stock?
VeinTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VeinTech's last funding round?
VeinTech's most recent funding round was VC Round on June 9, 2025.
Who are the main investors in VeinTech?
Key investors in VeinTech include Scale Investors, Perth Angels, Future Health Research and Innovation Fund, Rhode Island Life Science Hub, Australian Government Department of Industry, Science and Resources.
Will VeinTech IPO soon?
No public IPO plans have been announced for VeinTech.
How can I track VeinTech secondary market activity?
Caplight tracks bids, offers, and trades in VeinTech's shares on secondary markets.